Real-World Effectiveness and Safety of Saccharomyces boulardii CNCM I-745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp-EuReg)

by on 20 de juliol de 2026 with No hi ha comentaris
  • Nyssen, O. P., Jonaitis, L., Pérez-Aísa, Á., Tepes, B., Mahmudov, U., Voynovan, I., Martínez-Domínguez, S. J., Bujanda, L., Lucendo, A. J., Vologzanina, L., Garre, A., Lerang, F., Abdulkhakov, S. R., Pavoni, M., Denkovski, M., Mammadov, E., Leja, M., Tejedor-Tejada, J., Huguet, J. M., … Cano-Català, A., … Telaku, S. (2026). Real-World Effectiveness and Safety of Saccharomyces boulardii CNCM I-745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp-EuReg). Helicobacter, 31(2), e70119. https://doi.org/10.1111/hel.70119

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *